Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Seitz

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
RMD Open|March 22, 2024
DWI scrolling artery sign for the diagnosis of giant cell arteritis: a pattern recognition approachLuca Seitz, Susana Bucher, Lukas Bütikofer, et al.
Rheumatology (Oxford, England)|June 6, 2025
Efficacy of tocilizumab monotherapy after ultrashort glucocorticoid administration to treat giant cell arteritis: three-year follow-upLisa Christ, Luca Seitz, Godehard Scholz, et al.
Frontiers in Radiology|July 16, 2025
2D-cranial T1-black-blood MRI in suspected giant cell arteritis-measurement of vessel wall thickness does not give a diagnostic advantage compared to visual scoring alonePascal Seitz, Susana Bucher, Lukas Bütikofer, et al.
Rheumatology (Oxford, England)|August 9, 2023
Diffusion-weighted magnetic resonance imaging for the diagnosis of giant cell arteritis: a comparison with T1-weighted black-blood imagingLuca Seitz, Susana Bucher, Lukas Bütikofer, et al.
Rheumatology (Oxford, England)|July 22, 2024
Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumabLisa Christ, Harald M Bonel, Jennifer L Cullmann, et al.
Frontiers in Immunology|February 7, 2022
Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory DiseaseFabian Lötscher, Luca Seitz, Helena Simeunovic, et al.
Arthritis Research & Therapy|March 23, 2021
Vision loss in patients with giant cell arteritis treated with tocilizumabJennifer Amsler, Iveta Kysela, Christoph Tappeiner, et al.
The Lancet. Rheumatology|January 30, 2024
Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept studyLisa Christ, Luca Seitz, Godehard Scholz, et al.
Rheumatology (Oxford, England)|June 12, 2021
Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritisLuca Seitz, Lisa Christ, Fabian Lötscher, et al.
Rheumatology (Oxford, England)|January 24, 2024
Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumaticaPascal Seitz, Jennifer Cullmann, Susana Bucher, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
RMD Open|March 22, 2024
DWI scrolling artery sign for the diagnosis of giant cell arteritis: a pattern recognition approachLuca Seitz, Susana Bucher, Lukas Bütikofer, et al.
Rheumatology (Oxford, England)|June 6, 2025
Efficacy of tocilizumab monotherapy after ultrashort glucocorticoid administration to treat giant cell arteritis: three-year follow-upLisa Christ, Luca Seitz, Godehard Scholz, et al.
Frontiers in Radiology|July 16, 2025
2D-cranial T1-black-blood MRI in suspected giant cell arteritis-measurement of vessel wall thickness does not give a diagnostic advantage compared to visual scoring alonePascal Seitz, Susana Bucher, Lukas Bütikofer, et al.
Rheumatology (Oxford, England)|August 9, 2023
Diffusion-weighted magnetic resonance imaging for the diagnosis of giant cell arteritis: a comparison with T1-weighted black-blood imagingLuca Seitz, Susana Bucher, Lukas Bütikofer, et al.
Rheumatology (Oxford, England)|July 22, 2024
Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumabLisa Christ, Harald M Bonel, Jennifer L Cullmann, et al.
Frontiers in Immunology|February 7, 2022
Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory DiseaseFabian Lötscher, Luca Seitz, Helena Simeunovic, et al.
Arthritis Research & Therapy|March 23, 2021
Vision loss in patients with giant cell arteritis treated with tocilizumabJennifer Amsler, Iveta Kysela, Christoph Tappeiner, et al.
The Lancet. Rheumatology|January 30, 2024
Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept studyLisa Christ, Luca Seitz, Godehard Scholz, et al.
Rheumatology (Oxford, England)|June 12, 2021
Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritisLuca Seitz, Lisa Christ, Fabian Lötscher, et al.
Rheumatology (Oxford, England)|January 24, 2024
Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumaticaPascal Seitz, Jennifer Cullmann, Susana Bucher, et al.
Pageof 4